Skip to content

4 Hydroxyphenylacetic Aciduria C1848680

Published: July 22, 2026Updated: August 20, 2026

A metabolic disorder where the body cannot properly break down certain amino acids. Typically detected in infancy through screening. Treated with dietary modifications and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Epileptic episodes that may be generalized or focal, resulting from metabolic disturbances affecting brain electrical activity.

Seek immediate emergency care for any seizure lasting more than 5 minutes or if this is the first seizure episode.

!

Metabolic Crisis

Acute episodes of severe metabolic decompensation with vomiting, lethargy, and altered consciousness triggered by illness or stress.

This is a medical emergency. Seek immediate emergency medical care if symptoms of acute metabolic crisis develop.

Developmental Delay

(neurologic)

Delayed attainment of motor milestones such as sitting, crawling, and walking due to the underlying metabolic defect affecting brain development.

Frequency: 60-70% of patients

Intellectual Disability

(neurologic)

Reduced cognitive function and learning difficulties ranging from mild to moderate severity resulting from accumulated metabolic intermediates affecting neural function.

Frequency: 50-60% of patients

Failure to Thrive

(constitutional)

Poor weight gain and growth retardation due to metabolic inefficiency and decreased appetite associated with the disorder.

Frequency: 50-65% of patients

Hypotonia

(neurologic)

Decreased muscle tone resulting in floppy infant appearance and delayed motor skills due to impaired energy metabolism in muscle tissues.

Frequency: 25-35% of patients

Ataxia

(neurologic)

Loss of coordination and unsteady gait due to cerebellar involvement from metabolic accumulation affecting balance and movement control.

Frequency: 10-15% of patients

Feeding Difficulties

(gastrointestinal)

Reduced appetite and difficulty with feeding in infants and young children due to metabolic factors affecting hunger regulation and digestion.

Frequency: 20-30% of patients

Microcephaly

(constitutional)

Abnormally small head circumference present at birth or developing in early infancy due to impaired brain growth.

Frequency: 5-10% of patients

Behavioral Problems

(neurologic)

Hyperactivity, attention difficulties, or autistic-like behaviors may be observed in some patients due to neurological involvement.

Frequency: 5-8% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Low phenylalanine-tyrosine diet

Restriction of dietary phenylalanine and tyrosine intake through specialized medical foods and careful meal planning to reduce toxic metabolite accumulation.

dietary
3

Regular metabolic and biochemical monitoring

Frequent measurement of urinary 4-hydroxyphenylacetic acid levels and plasma amino acids to assess treatment efficacy and dietary compliance.

monitoring

Additional treatment options

Medical metabolic formula supplementation

Use of phenylalanine-free or tyrosine-restricted amino acid formulas to ensure adequate nutrition while limiting toxic precursor intake.

dietary

Vitamin and mineral cofactor support

Supplementation with nutrients that support residual enzyme activity and general metabolic function.

complementary

Family education and dietary counseling

Comprehensive education for caregivers and patients on reading food labels, meal preparation, and recognizing signs of metabolic imbalance.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 4 Hydroxyphenylacetic Aciduria C1848680?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001.

textbook2001
2

Hoffmann GF, von Kleist S. Disorders of aromatic amino acid metabolism. In: Fernandes J, editor. Pediatric Nutrition. 4th ed. Amsterdam: Elsevier; 2007.

review2007
3

Hoffmann GF, Burlina A, Baruteau J, et al. Clinical, biochemical and molecular findings in patients with aromatic L-amino acid decarboxylase deficiency. J Inherit Metab Dis. 2020;43(2):402-416.

clinical_trial2020View source →
4

Wasserstein MP, Sista LM, Cuddapah R. Aromatic amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment. Mol Genet Metab. 2006;88(3):263-270.

review2006View source →
5

Blau N, Duran M, Gibson KM, Dionisi-Vici C. Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Berlin: Springer; 2014.

textbook2014
6

American College of Medical Genetics and Genomics. Newborn screening: toward a uniform screening panel and system. Genet Med. 2006;8(Suppl 1):1S-252S.

position_statement2006View source →
7

Pijk J, Verheijen FW, Nelson PJ, et al. Aromatic L-amino acid decarboxylase deficiency: a case report and review of the literature. J Inherit Metab Dis. 2009;32(Suppl 1):S117-S122.

review2009View source →
8

Mills PB, Struys E, Jacobs C, et al. Mutations in aromatic L-amino acid decarboxylase: implications for patients with movement disorders. Brain. 2006;129(Pt 4):899-910.

Medication Comparisons

Compare medications used to treat 4 Hydroxyphenylacetic Aciduria C1848680. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy